BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21742099)

  • 1. Growth differentiation factor 15: an additional diagnostic tool for the risk stratification of developing heart failure in patients with operated congenital heart defects?
    Norozi K; Buchhorn R; Yasin A; Geyer S; Binder L; Seabrook JA; Wessel A
    Am Heart J; 2011 Jul; 162(1):131-5. PubMed ID: 21742099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
    Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
    J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth differentiation factor 15: a novel risk marker adjunct to the EuroSCORE for risk stratification in cardiac surgery patients.
    Heringlake M; Charitos EI; Gatz N; Käbler JH; Beilharz A; Holz D; Schön J; Paarmann H; Petersen M; Hanke T
    J Am Coll Cardiol; 2013 Feb; 61(6):672-81. PubMed ID: 23391200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction.
    Kempf T; Björklund E; Olofsson S; Lindahl B; Allhoff T; Peter T; Tongers J; Wollert KC; Wallentin L
    Eur Heart J; 2007 Dec; 28(23):2858-65. PubMed ID: 17977844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.
    Anand IS; Kempf T; Rector TS; Tapken H; Allhoff T; Jantzen F; Kuskowski M; Cohn JN; Drexler H; Wollert KC
    Circulation; 2010 Oct; 122(14):1387-95. PubMed ID: 20855664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in children with congenital heart defects and open-heart surgery.
    Gessler P; Knirsch W; Schmitt B; Rousson V; von Eckardstein A
    J Pediatr; 2006 Mar; 148(3):372-6. PubMed ID: 16615970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pacemaker implantation as a risk factor for heart failure in young adults with congenital heart disease.
    Nothroff J; Norozi K; Alpers V; Arnhold JO; Wessel A; Ruschewski W; Buchhorn R
    Pacing Clin Electrophysiol; 2006 Apr; 29(4):386-92. PubMed ID: 16650267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth-differentiation factor-15 in heart failure.
    Kempf T; Wollert KC
    Heart Fail Clin; 2009 Oct; 5(4):537-47. PubMed ID: 19631178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.
    Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P
    Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of N-terminal-pro-brain natriuretic peptide in congenital heart disease surgery and its value as a predictive biomarker.
    Pérez-Piaya M; Abarca E; Soler V; Coca A; Cruz M; Villagrá F; Giannivelli S; Asensio A
    Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):461-6. PubMed ID: 21131684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of growth hormone treatment on B-type natriuretic peptide as a marker of heart failure in adults with growth hormone deficiency.
    Wallaschofski H; Saller B; Spilcke-Liss E; Lerch MM; Lohmann T; Eigenthaler M
    Horm Metab Res; 2006 Oct; 38(10):656-61. PubMed ID: 17075774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification in chronic heart failure: independent and incremental prognostic value of echocardiography and brain natriuretic peptide and its N-terminal fragment.
    Bruch C; Rothenburger M; Gotzmann M; Sindermann J; Scheld HH; Breithardt G; Wichter T
    J Am Soc Echocardiogr; 2006 May; 19(5):522-8. PubMed ID: 16644435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison study on diagnostic and prognostic value of N-terminal pro-brain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Li YJ; Wang L; Chen KY; Chen YL; Cai JR; Zhou LJ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):544-7. PubMed ID: 16146600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of supraventricular arrhythmia in adults with congenital heart disease.
    Trojnarska O; Grajek S; Kramer L; Gwizdała A
    Cardiol J; 2009; 16(3):218-26. PubMed ID: 19437395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Natriuretic peptides--new diagnostic markers in heart disease].
    Angermann CE; Ertl G
    Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure.
    Law YM; Ettedgui J; Beerman L; Maisel A; Tofovic S
    Am J Cardiol; 2006 Aug; 98(4):520-4. PubMed ID: 16893709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.